Spain operates the largest publicly supported knee OA cell therapy programme, with 20+ specialised centres and decades of registry data. South Korea excels in high-volume, cost-effective delivery with rapid access. Germany and Switzerland prioritise regulatory rigour and transparent outcomes. UAE and Mexico offer efficient treatment pathways with international patient accommodation. For evidence-based protocols and long-term follow-up integration, Spanish and German centres lead; for rapid, affordable access, South Korea and Portugal are preferred.
Knee OA cell therapy ranges from €3,500–6,500 per knee in European centres. Placental MSC intra-articular injection (€4,000–5,500) is most common. Autologous chondrocyte implantation commands premium pricing (€6,000–8,000) owing to required surgical harvest and extended culture. Exosome-based intra-articular therapies cost €3,500–5,000. Bilateral knees require separate procedures, doubling cost. Repeat injections (often recommended at 6–12 month intervals) significantly increase lifetime expenditure. Insurance selectively reimburses in some European countries (e.g., Spain, Germany) under medical necessity frameworks; US coverage is rare.
Съм ли кандидат? → · Knee Osteoarthritis: full overview → · Цена Артроза на коляното → · Cost →
Медицински преглед от редакционния екип на StemCellAtlas с Dr Tymur Lukyanenko (Orthopaedic Traumatologist · 20+ yrs clinical, 15+ yrs cell therapy) на партньорската клиника Stem Plus (София), спрямо ISSCR, FDA и EMA указания. Educational information, not medical advice; figures indicative.
GMP-сертифицирана регенеративна медицина в сърцето на ЕС — от 3 000–8 000 €, част от цените в САЩ или Германия. Персонализирани протоколи за пациенти от над 50 държави.
Безплатна медицинска оценка